Electrochemical Point-of-Care (POC) devices for bacteria detection

SENSàSION has signed a distribution agreement with Igenetec Diagnostics (Shanghai, China) for molecular diagnostic device (RT-PCR) and serology tests (IgG, IgM, antigen). The instruments and tests are currently for Research Use Only (RUO).

MD_edited.png
MD%20kit_edited.png

Reader: Microfluidics Isothermal Amplification Nucleic Acid Analyzer Model: MA2000

Kit components:

1) Coronavirus SARS-CoV-2 Nucleic Acid detection kit 

2) Nucleic acid extraction reagents kit

3) Swab sampling tube

Immuno3.jpg

Reader: Immunofluorescence analyzer Model: MI300

Test: SARS-CoV-2 IgG

SARS-CoV-2 IgM

SARS-CoV-2 Antigen

MI%20300_edited.png
IMG_7890_01_edited.png
IMG_7890_02_edited.png

Lateral flow assay (LFA) for qualitative detection of SARS-CoV-2 IgG/IgM antibody in human whole blood (venous blood and peripheral blood), plasma and serum.

Why POC?

  • Doctor and patient both get faster test results

  • More convenient for patient and provider

  • Proven increased patient satisfaction

  • Decrease in overall cost of care

Vision

Bring to the doctors’ practices and their analytical laboratory services novel electrochemical point-of-care (POC) device for the fast and reliable detection of live bacteria in biological samples and detection of their antimicrobial susceptibility.

Video interview with Peter Harboe-Schmidt from the Life Science Series event - BioArk, Monthey

May 25, 2020

Heidi News: Oubliées par la Confédération, les start-up suisses multiplient les solutions face au Covid-19

April 13, 2020

Le Nouvelliste: Coronavirus - des tests d’immunité pourraient être mis sur le marché grâce à une start-up sédunoise

April 13, 2020

Canal9: Savoir qui est immunisé pour sortir de la crise: le prochain défi d’une startup sédunois

April 13, 2020

1/2
Please reload

Follow

Contact

Address

SENSàSION Sàrl, rue de l'Industrie 17, 1950 Sion, Valais, Switzerland

©2018 BY SENSÀSION.